Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-21-000018 General Corporate
Debt relative to revenue 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
170.15% · OPTIONAL · VALID
Capex intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.49% · OPTIONAL · VALID
Operating cash generation 35th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
12.08% · OPTIONAL · VALID
Revenue growth 100th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
12.99% · CORE · VALID
Inventory pressure 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
71.87% · OPTIONAL · VALID
Gross margin 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
36.16% · CORE · VALID
Operating margin 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
15.22% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.73% · OPTIONAL · VALID
SBC intensity 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.55% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 177.19%
Current 170.15%
Delta -7.03% Capex Intensity Increased
Previous 1.43%
Current 1.49%
Delta 0.06% Cash Generation Increased
Previous -4.46%
Current 12.08%
Delta 16.54% Growth Increased
Previous -0.69%
Current 12.99%
Delta 13.68% Inventory Pressure Decreased
Previous 74.81%
Current 71.87%
Delta -2.93% Margin Increased
Previous 35.13%
Current 36.16%
Delta 1.03% Profitability Increased
Previous 14.25%
Current 15.22%
Delta 0.97% R And D Intensity Increased
Previous 3.66%
Current 3.73%
Delta 0.07% Sbc Intensity Decreased
Previous 0.56%
Current 0.55%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.